|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
FISH, AML Panel
Test Code902201
CPT Codes
88271 (x21), 88275 (x11)<br /> Restricted Client Code
Includes
19799 - FISH, MDS/Myeloid Panel, -5/5q-,-7/7q-, +8,20q-
36055 - FISH, Myeloid Lymphoid Leukemia (MLL) (11q23), Gene Rearrangement
16670 - Chromosome FISH, D13S319, del 13q14.3
17874 - FISH, p53, Deletion 17p13.1
91391 - FISH, Myeloid Neoplasms, MECOM (EVI1), 3q26.2
10106 - FISH, RUNX1T1/RUNX1 (ETO/AML1), Translocation (8;21)
14617 - FISH, APL, PML/RARA, Translocation 15,17
10635 - FISH, AML M4, CBFB/MYH11, Inversion 16
12070 - FISH, CML/ALL, BCR/ABL Translocation 9, 22
36055 - FISH, Myeloid Lymphoid Leukemia (MLL) (11q23), Gene Rearrangement
16670 - Chromosome FISH, D13S319, del 13q14.3
17874 - FISH, p53, Deletion 17p13.1
91391 - FISH, Myeloid Neoplasms, MECOM (EVI1), 3q26.2
10106 - FISH, RUNX1T1/RUNX1 (ETO/AML1), Translocation (8;21)
14617 - FISH, APL, PML/RARA, Translocation 15,17
10635 - FISH, AML M4, CBFB/MYH11, Inversion 16
12070 - FISH, CML/ALL, BCR/ABL Translocation 9, 22
Preferred Specimen
Please see the individual tests for specimen requirements
Instructions
Clinical history/reason for referral is required with test order. Prior therapy and transplant history should be provided with test order.
Specimen viability decreases during transit. Send specimen to testing lab for viability determination. Do not reject.
Specimen viability decreases during transit. Send specimen to testing lab for viability determination. Do not reject.
Specimen Stability
See individual tests
Methodology
Fluorescence In Situ Hybridization
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Daily; Report available: 8 days
Reference Range
See individual tests